# Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

> **NCT00556452** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 46 (actual)

## Conditions studied

- Leukemia
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Clofarabine/Busulfan x 4
- **PROCEDURE:** Peripheral blood stem cell transplant
- **RADIATION:** Total Lymphoid Irradiation

## Key facts

- **NCT ID:** NCT00556452
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-06
- **Final completion:** 2012-09
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556452, "Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00556452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*